{"transactions":[{"id":9561,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:57:24.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8391,"source":{"system":"sec-edgar","filing":"0000318154-26-000100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000100/form4.xml","form_type":"4"}},{"id":23560,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-29T00:58:40.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 417 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":7569,"source":{"system":"sec-edgar","filing":"0001127602-25-015850","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225015850/form4.xml","form_type":"4"}},{"id":40129,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-04T23:25:00.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 471 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":6472,"source":{"system":"sec-edgar","filing":"0001127602-24-017807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224017807/form4.xml","form_type":"4"}},{"id":1500516,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-28T16:40:01.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 23, 2025, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":0.7036,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-065299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000095017024065299/ownership.xml","form_type":"4"}},{"id":1874977,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T16:05:33.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 25, 2024, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":1.62,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-23-014051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924323014051/doc4.xml","form_type":"4"}},{"id":55631,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-23T23:19:52.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 406 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":5688,"source":{"system":"sec-edgar","filing":"0001127602-23-016633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223016633/form4.xml","form_type":"4"}},{"id":2251542,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-31T16:06:07.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 26, 2023, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":1.61,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-020149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924322020149/doc4.xml","form_type":"4"}},{"id":66068,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-20T01:52:07.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 257 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":4600,"source":{"system":"sec-edgar","filing":"0001127602-22-015173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222015173/form4.xml","form_type":"4"}},{"id":87111,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-20T23:22:34.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 146 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":3634,"source":{"system":"sec-edgar","filing":"0001127602-21-017697","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221017697/form4.xml","form_type":"4"}},{"id":2712522,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T17:23:34.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 13, 2022, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":20000,"derivative":{"exercise_price":16.34,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-019559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924321019559/doc4.xml","form_type":"4"}},{"id":2931529,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-28T21:24:49.000Z","date":"2020-12-23","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of December 23, 2021, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":6667,"derivative":{"exercise_price":19,"expiration_date":"2030-12-23","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0000899243-20-035387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924320035387/doc4.xml","form_type":"4"}},{"id":2931528,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T21:24:49.000Z","date":"2020-12-23","kind":"grant","acquired":true,"shares":54806,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received pursuant to the Merger Agreement, dated as of September 25, 2020, by and among LifeSci Acquisition Corp. (\"LifeSci\"), Vincera Pharma, Inc. (\"Legacy Vincera\") and LifeSci Acquisition Merger Sub, Inc., a wholly-owned subsidiary of LifeSci (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Legacy Vincera, with Legacy Vincera surviving the merger as a wholly-owned subsidiary of LifeSci (which subsequently changed its name to \"Vincera Pharma, Inc.\")."}],"balance_after":54806,"source":{"system":"sec-edgar","filing":"0000899243-20-035387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924320035387/doc4.xml","form_type":"4"}},{"id":104979,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-08T00:31:43.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":2719,"source":{"system":"sec-edgar","filing":"0001127602-20-015846","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015846/form4.xml","form_type":"4"}},{"id":116908,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-07T22:16:47.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 14 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":1819,"source":{"system":"sec-edgar","filing":"0001127602-19-017635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017635/form4.xml","form_type":"4"}},{"id":126296,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-02T22:26:36.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":678,"source":{"system":"sec-edgar","filing":"0001127602-18-024505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218024505/form4.xml","form_type":"4"}}]}